Literature DB >> 26311332

[Atrial appendage occlusion in atrial fibrillation? Con].

P D Schellinger1, M Köhrmann2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26311332     DOI： 10.1007/s00115-015-4282-0

Source DB:  PubMed          Journal:  Nervenarzt        ISSN： 0028-2804            Impact factor:   1.214


× No keyword cloud information.
  12 in total

1.  Percutaneous left atrial appendage closure vs warfarin for atrial fibrillation: a randomized clinical trial.

Authors:  Vivek Y Reddy; Horst Sievert; Jonathan Halperin; Shephal K Doshi; Maurice Buchbinder; Petr Neuzil; Kenneth Huber; Brian Whisenant; Saibal Kar; Vijay Swarup; Nicole Gordon; David Holmes
Journal:  JAMA       Date:  2014-11-19       Impact factor: 56.272

2.  The left atrial appendage: our most lethal human attachment! Surgical implications.

Authors:  W D Johnson; A K Ganjoo; C D Stone; R C Srivyas; M Howard
Journal:  Eur J Cardiothorac Surg       Date:  2000-06       Impact factor: 4.191

Review 3.  Left atrial appendage closure: a percutaneous transcatheter approach for stroke prevention in atrial fibrillation.

Authors:  Ulf Landmesser; David R Holmes
Journal:  Eur Heart J       Date:  2011-10-31       Impact factor: 29.983

4.  Apixaban versus warfarin in patients with atrial fibrillation.

Authors:  Christopher B Granger; John H Alexander; John J V McMurray; Renato D Lopes; Elaine M Hylek; Michael Hanna; Hussein R Al-Khalidi; Jack Ansell; Dan Atar; Alvaro Avezum; M Cecilia Bahit; Rafael Diaz; J Donald Easton; Justin A Ezekowitz; Greg Flaker; David Garcia; Margarida Geraldes; Bernard J Gersh; Sergey Golitsyn; Shinya Goto; Antonio G Hermosillo; Stefan H Hohnloser; John Horowitz; Puneet Mohan; Petr Jansky; Basil S Lewis; Jose Luis Lopez-Sendon; Prem Pais; Alexander Parkhomenko; Freek W A Verheugt; Jun Zhu; Lars Wallentin
Journal:  N Engl J Med       Date:  2011-08-27       Impact factor: 91.245

5.  Apixaban in patients with atrial fibrillation.

Authors:  Stuart J Connolly; John Eikelboom; Campbell Joyner; Hans-Christoph Diener; Robert Hart; Sergey Golitsyn; Greg Flaker; Alvaro Avezum; Stefan H Hohnloser; Rafael Diaz; Mario Talajic; Jun Zhu; Prem Pais; Andrzej Budaj; Alexander Parkhomenko; Petr Jansky; Patrick Commerford; Ru San Tan; Kui-Hian Sim; Basil S Lewis; Walter Van Mieghem; Gregory Y H Lip; Jae Hyung Kim; Fernando Lanas-Zanetti; Antonio Gonzalez-Hermosillo; Antonio L Dans; Muhammad Munawar; Martin O'Donnell; John Lawrence; Gayle Lewis; Rizwan Afzal; Salim Yusuf
Journal:  N Engl J Med       Date:  2011-02-10       Impact factor: 91.245

6.  Percutaneous left atrial appendage closure for stroke prophylaxis in patients with atrial fibrillation: 2.3-Year Follow-up of the PROTECT AF (Watchman Left Atrial Appendage System for Embolic Protection in Patients with Atrial Fibrillation) Trial.

Authors:  Vivek Y Reddy; Shephal K Doshi; Horst Sievert; Maurice Buchbinder; Petr Neuzil; Kenneth Huber; Jonathan L Halperin; David Holmes
Journal:  Circulation       Date:  2013-01-16       Impact factor: 29.690

7.  Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial.

Authors:  David R Holmes; Saibal Kar; Matthew J Price; Brian Whisenant; Horst Sievert; Shephal K Doshi; Kenneth Huber; Vivek Y Reddy
Journal:  J Am Coll Cardiol       Date:  2014-07-08       Impact factor: 24.094

8.  Dabigatran versus warfarin in patients with atrial fibrillation.

Authors:  Stuart J Connolly; Michael D Ezekowitz; Salim Yusuf; John Eikelboom; Jonas Oldgren; Amit Parekh; Janice Pogue; Paul A Reilly; Ellison Themeles; Jeanne Varrone; Susan Wang; Marco Alings; Denis Xavier; Jun Zhu; Rafael Diaz; Basil S Lewis; Harald Darius; Hans-Christoph Diener; Campbell D Joyner; Lars Wallentin
Journal:  N Engl J Med       Date:  2009-08-30       Impact factor: 91.245

9.  Percutaneous left atrial appendage closure for stroke prevention in patients with atrial fibrillation: an assessment of net clinical benefit.

Authors:  Sandeep R Gangireddy; Jonathan L Halperin; Valentin Fuster; Vivek Y Reddy
Journal:  Eur Heart J       Date:  2012-09-24       Impact factor: 29.983

10.  Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial.

Authors:  David R Holmes; Vivek Y Reddy; Zoltan G Turi; Shephal K Doshi; Horst Sievert; Maurice Buchbinder; Christopher M Mullin; Peter Sick
Journal:  Lancet       Date:  2009-08-15       Impact factor: 79.321
View more
  1 in total

Review 1.  [Left atrial appendage occlusion in patients with nonvalvular atrial fibrillation : Present evidence, ongoing studies, open questions].

Authors:  K G Häusler; M Endres; U Landmesser
Journal:  Med Klin Intensivmed Notfmed       Date:  2018-11-27       Impact factor: 0.840
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.